Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey

Table of Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 INTRODUCTION TO EMERGING PHARMACEUTICAL MARKETS

• Why are emerging markets of interest now
  • Attractions - reasons to go
  • Reasons not to go
• Regions

CHAPTER 3 RUSSIAN PHARMACEUTICAL MARKET

• Demographic trends
  • Basic facts
  • Life expectancy
  • Ageing and depopulation
• Disease burden
• Healthcare system
  • Mandatory health insurance was introduced in 1991
  • Certain diseases have become a priority of the Russian government
  • Healthcare expenditure is below the level of Western EU countries
  • Primary vs hospital healthcare
  • Under the table spend
  • Access to healthcare is especially problematic for the poor population
  • Companies offering private health insurance are scarce and focus on the top end of the market
• Pricing and reimbursement of drugs
  • Pricing of drugs
  • Reimbursement
  • DLO
• Regulatory
  • Intellectual property protection
  • Patents
  • Data exclusivity
  • Counterfeiting
  • Registration of drugs
  • The majority of drugs are sold without a prescription.
• Socioeconomic environment
  • Economic
  • The Russian economy is trying to break away from overdependence on natural resources and is diversifying
  • The population is highly educated but the output is low
  • Looming labor shortage
  • Regional differences
  • Accession to WTO
  • Foreign investment
• Political climate
  • Russia remains a centralized country with the center of power in Moscow
  • Corruption
• Corporate
  • Bureaucracy- red tape
  • Registration of a legal entity in Russia is a long and costly procedure
  • Taxation differs for foreign companies
  • Customs
• Pharmaceutical market dynamics
  • The distribution segment is fragmented but is consolidating
  • The pharmacy networks segment is fragmented
  • Sales of pharmaceuticals
  • Global pharma lead the Russian pharmaceutical market by sales value
  • Retail sales
  • Hospital sales
  • DLO is one of the major growth drivers of the Russian pharmaceutical market
  • Import
  • Export
  • Launch, marketing and branding
  • Which drugs to market
  • Market entry strategies
• Major foreign players
  • Sanofi-Aventis is the top foreign pharmaceutical company in Russia
  • Novartis' s presence in Russia is growing
  • Servier
  • Roche
  • Gedeon Richter
  • Nycomed
  • Eli Lilly
  • Novo Nordisk
  • Bayer
  • Other Foreign companies are acquiring manufacturing facilities in Russia
• Major domestic players
  • Innovation is lagging behind the West
  • The Russian pharmaceutical market will continue to grow
• Manufacturing drugs in Russia
• Clinical trials

CHAPTER 4 TURKEY

CHAPTER 5 BRAZIL

CHAPTER 6 INDIA

CHAPTER 7 CHINA

CHAPTER 8 SCORECARDS FOR ANALYZED COUNTRIES - A FRAMEWORK FOR EMERGING MARKET ANALYSIS

CHAPTER 9 BIBLIOGRAPHY

APPENDIX

NOTE: Turkey, Brazil, India and China chapters will follow the same structure as Russia.